Mariko Tokiwa

Kobe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.

Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.

Journal: Future oncology (London, England)

Published: October 24, 2025

Prognostic Impact of De-escalation Therapy in Older Adults With Breast Cancer: A Retrospective Cohort Study.

Prognostic Impact of De-escalation Therapy in Older Adults With Breast Cancer: A Retrospective Cohort Study.

Journal: Cureus

Published: October 03, 2025

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.

Journal: Breast cancer research and treatment

Published: September 12, 2025

Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer.

Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer.

Journal: Endocrine-related cancer

Published: December 26, 2024

A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B).

A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 29, 2024

Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study.

Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study.

Journal: Breast cancer (Tokyo, Japan)

Published: January 18, 2024

Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study).

Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study).

Journal: Japanese journal of clinical oncology

Published: August 24, 2022

Multimodal imaging of right ventricular obstruction due to metastatic cardiac tumour.

Multimodal imaging of right ventricular obstruction due to metastatic cardiac tumour.

Journal: European heart journal. Case reports

Published: May 04, 2021

Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.

Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.

Journal: Cancer & metabolism

Published: August 14, 2020

High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer.

High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer.

Journal: British journal of cancer

Published: May 16, 2019

Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.

Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.

Journal: Cancer & metabolism

Published: February 23, 2019

Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.

Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.

Journal: Breast cancer (Tokyo, Japan)

Published: April 03, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026